Prudential Financial
NERV icon

Prudential Financial’s Minerva Neurosciences NERV Stock Holding History

Prudential Financial’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,422
Closed -$77K – 2457
2018
Q4 		$77K Buy
+1,422
New +$104K ﹤0.01% 2321

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IVAV
Index Venture Associates V St. Helier, Channel Islands, Jersey $1.46M AUM 88.05% 1-Year Est. Return

Prudential Financial's NERV Position: Q1 2019 in Review

Prudential Financial sold out of Minerva Neurosciences (NERV) in Q1 2019, closing a stake of 1,422 shares — an estimated $77K sold.

Prudential Financial first reported a position in NERV in Q4 2018 and held it in 1 quarter. The position peaked at $77K in Q4 2018. 79 funds tracked by Wall St. Rank hold NERV as of Q1 2019.

  • Prudential Financial reported no remaining Minerva Neurosciences position as of Q1 2019 after selling out during the quarter.
  • Prudential Financial sold 1,422 Minerva Neurosciences shares in Q1 2019, an estimated $77K.
  • Prudential Financial first reported a position in Minerva Neurosciences in Q4 2018 and held it in 1 quarter.
  • Prudential Financial's Minerva Neurosciences position peaked at $77K in Q4 2018.
  • 79 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2019.

Based on Prudential Financial's 13F filing for Q1 2019, filed 15 May 2019.